» Articles » PMID: 37998468

Association Between Chronic Kidney Disease and Dynapenia in Elderly Koreans

Overview
Specialty Health Services
Date 2023 Nov 24
PMID 37998468
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic kidney disease (CKD) is caused by various factors such as chronic inflammation, oxidative stress, and obesity. Loss of muscle strength and mass is a negative prognostic factor for CKD. Therefore, in this study, we aimed to investigate the association between CKD and dynapenia in the Korean elderly. To this end, we analyzed 7029 participants from the 2014-2019 Korean National Health and Nutrition Examination Survey (KNHANES) aged ≥65 years. After adjusting for all of the covariates that could affect the results, such as physical examinations, lifestyle factors, and exercise, the association between CKD and dynapenia was found to be significant, at 1.207 (95% CI: 1.056-1.379) in CKD stage 2 and 1.790 (95% CI: 1.427-2.246) in CKD stage 3a-5. However, when sexes were analyzed separately, women were significant in both CKD stage 2 and stage 3-5 compared to normal, but only in stage 3-5 for men. Additionally, the prevalence of dynapenia increased significantly as the stage of CKD increased (normal, stage 2, and stage 3-5: 18.5%, 20.8%, and 32.3% in men and 27.5%, 34.4%, and 46.1% in women, respectively). Thus, CKD is significantly related to dynapenia, especially in women, when stratified by sex.

Citing Articles

Prevalence and Risk Factors for Hand-Grip-Determined Dynapenia in the Korean Population: A Cross-Sectional Study.

Lee D Sports (Basel). 2024; 12(7).

PMID: 39058078 PMC: 11281309. DOI: 10.3390/sports12070187.


Prevalence and Risk Factors of Osteoarthritis in Korea: A Cross-Sectional Study.

Lee D Medicina (Kaunas). 2024; 60(4).

PMID: 38674311 PMC: 11052057. DOI: 10.3390/medicina60040665.

References
1.
Verzola D, Procopio V, Sofia A, Villaggio B, Tarroni A, Bonanni A . Apoptosis and myostatin mRNA are upregulated in the skeletal muscle of patients with chronic kidney disease. Kidney Int. 2011; 79(7):773-82. DOI: 10.1038/ki.2010.494. View

2.
Chen L, Liu L, Woo J, Assantachai P, Auyeung T, Bahyah K . Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014; 15(2):95-101. DOI: 10.1016/j.jamda.2013.11.025. View

3.
Schardong J, Zago Marcolino M, Plentz R . Muscle Atrophy in Chronic Kidney Disease. Adv Exp Med Biol. 2018; 1088:393-412. DOI: 10.1007/978-981-13-1435-3_18. View

4.
Garibotto G, Sofia A, Russo R, Paoletti E, Bonanni A, Parodi E . Insulin sensitivity of muscle protein metabolism is altered in patients with chronic kidney disease and metabolic acidosis. Kidney Int. 2015; 88(6):1419-1426. PMC: 4678169. DOI: 10.1038/ki.2015.247. View

5.
Guida B, Di Maro M, Di Lauro M, Lauro T, Trio R, Santillo M . Identification of sarcopenia and dynapenia in CKD predialysis patients with EGWSOP2 criteria: An observational, cross-sectional study. Nutrition. 2020; 78:110815. DOI: 10.1016/j.nut.2020.110815. View